Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

Peden, 2002

Gosselin, 2009, Injuries: the neglected burden in developing countries, Bull World Health Organ, 87, 246, 10.2471/BLT.08.052290

Sauaia, 1995, Epidemiology of trauma deaths: a reassessment, J Trauma, 38, 185, 10.1097/00005373-199502000-00006

Lawson, 2004, Challenges for providing effective hemostasis in surgery and trauma, Sem Hematol, 41, 55, 10.1053/j.seminhematol.2003.11.012

Henry, 2007, Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD001886.pub2

Okamoto, 1997, Enzyme controlling medicines: introduction, Semin Thromb Hemost, 23, 493, 10.1055/s-2007-996127

Coats, 2004, Antifibrinolytic drugs for acute traumatic injury, Cochrane Database Syst Rev, 4, 10.1002/14651858.CD004896.pub2

Baigent, 2010, Large-scale randomized evidence: trials and meta-analyses of trials, 31

Perel, 2008, Use of the Oxford Handicap Scale at hospital discharge to predict Glasgow Outcome Scale at 6 months in patients with traumatic brain injury, BMC Med Res Methodol, 8, 72, 10.1186/1471-2288-8-72

Duley, 2008, Specific barriers to the conduct of randomized trials, Clin Trials, 5, 40, 10.1177/1740774507087704

Sterne, 2009, Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls, BMJ, 338, b2393, 10.1136/bmj.b2393

Rogers, 1995, Systematic underestimation of treatment effects as a result of diagnostic test inaccuracy: implications for the interpretation and design of thromboprophylaxis trials, Thromb Haemost, 73, 167, 10.1055/s-0038-1653746

Brohi, 2008, Acute coagulopathy of trauma: hypo-perfusion induces systemic anticoagulation and hyper-fibrinolysis, J Trauma, 64, 1211, 10.1097/TA.0b013e318169cd3c

Ekbäck, 2000, Tranexamic acid reduces blood loss in total hip replacement surgery, Anesth Analg, 91, 1124, 10.1213/00000539-200011000-00014

Kauvar, 2006, Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations, J Trauma, 60, S3, 10.1097/01.ta.0000199961.02677.19

Mock, 1998, Trauma mortality patterns in three nations at different economic levels: implications for global trauma system development, J Trauma, 44, 804, 10.1097/00005373-199805000-00011

Wyatt, 1995, The time of death after trauma, BMJ, 310, 1502, 10.1136/bmj.310.6993.1502

Fiechtner, 2001, Plasma tranexamic acid concentrations during cardiopulmonary bypass, Anesth Analg, 92, 1131, 10.1097/00000539-200105000-00010

Horrow, 1995, The dose-response relationship of tranexamic acid, Anesthesiology, 82, 383, 10.1097/00000542-199502000-00009

2008, Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients, BMJ, 12, 12

Maas, 2007, Prognostic value of computerized tomography scan characteristics in traumatic brain injury: results from the IMPACT study, J Neurotrauma, 24, 303, 10.1089/neu.2006.0033

Perel, 2009, Intracranial bleeding in patients with traumatic brain injury: a prognostic study, BMC Emerg Med, 9, 15, 10.1186/1471-227X-9-15

Hogan, 2010, Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5, Lancet, 375, 1609, 10.1016/S0140-6736(10)60518-1

Ferrer, 2009, Anti-fibrinolytic agents in postpartum haemorrhage: a systematic review, BMC Pregnancy Childbirth, 9, 29, 10.1186/1471-2393-9-29

Shakur, 2010, The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial, Trials, 11, 40, 10.1186/1745-6215-11-40